Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if oral Heme Iron Polypeptide is as effective as
intravenous (IV) iron sucrose in the treatment of iron-deficiency anemia for patients with
chronic kidney disease.